InvestorsHub Logo
Followers 56
Posts 2632
Boards Moderated 0
Alias Born 02/01/2017

Re: Hbpainter post# 228650

Friday, 05/24/2019 11:11:53 AM

Friday, May 24, 2019 11:11:53 AM

Post# of 689044
While Carlo Rago's presentation is very interesting, a correction may be in order. Dr. Rago"s states that based on Linda Liau's 2019 video, he can conservatively estimate that at least 51 of the 331 patients (15%) survived 5(+) years without progression.

However, what I heard in Dr. Liau's video and it matches Sentiment stocks' transcription of the video, seems to indicate that Dr.Liau said that the majority of the approx 93 patients (28.2% of 331) who survived 36(+) months enjoyed a PFS status at that time (36 months). That would mean that at least about 47 post 36 months survivors were still PFS at 36(+) months.



https://www.scribd.com/document/411229128/A-Dendritic-Cell-Cancer-Vaccine-Shines-Brighter-for-Glioblastoma-Patients

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News